Other cross-sectional studies have demonstrated relationships between KIR–HLA and HCV-related HCC [16,17], although none have addressed the development of HCC in HCV patients over long-term follow-up. This evidence concerns the gene KIR3DL1 and hepatocellular carcinoma.